NextCure, Inc. (NXTC) Misses Q2 EPS by 17c

NextCure, Inc. (NASDAQ: NXTC) reported Q2 EPS of ($0.55), $0.17 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Exclusive: J&J Snack Foods CEO sees a leaner business set up to return to growth
• Citi reiterates Buy rating on AMD with $575 price target post TMT conference